Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity

Medicine & Life Sciences

• LDL Lipoproteins 100%
• Molecular Biology 78%
• VLDL Lipoproteins 26%
• Triglycerides 26%
• HDL Lipoproteins 22%
• Nonesterified Fatty Acids 22%
• Coronary Artery Disease 22%
• Cholesterol Esters 19%
• Lipoprotein Lipase 19%
• IDL Lipoproteins 16%
• Apolipoprotein B-100 15%
• Cholesterol Ester Transfer Proteins 15%
• Liver 11%
• Adipocytes 10%
• Insulin Resistance 8%
• Familial Combined Hyperlipidemia 8%
• very low density lipoprotein triglyceride 7%
• VLDL Cholesterol 7%
• Lipids 7%
• lipoprotein cholesterol 6%
• Chromosomes, Human, Pair 1 6%
• low density lipoprotein triglyceride 6%
• LDL Receptors 6%
• Hypertriglyceridemia 6%
• Intra-Abdominal Fat 6%
• Lipase 5%
• Dyslipidemias 5%
• Proteolysis 5%
• Hydrolysis 4%
• Metabolic Syndrome 4%
• LDL Cholesterol 4%
• Fatty Acids 4%
• Adipose Tissue 4%
• Epidemiologic Studies 4%
• Atherosclerosis 4%
• Endothelial Cells 3%
• Animal Models 3%
• Therapeutics 3%
• Clinical Trials 3%
• Hypertension 3%
• Gene Expression 3%
• Inflammation 3%
• Pharmaceutical Preparations 2%
• Genes 2%
• Proteins 1%